What happens when private equity exits physician practices? @toriberquist, @LeemoreDafny, and I find PE sales of physician practices lead to higher physician turnover and more doctors moving to large practices. In JAMA Health Forum:

Jesus, famously known for his love of medical debt collection

types of health policy papers

I haven't written a column in a while, because I've been noodling over a big question: Why are debates over reforming our health care system so unproductive? I think we've been focusing on the wrong things. Please read this guess essay in @nytopinion https://t.co/4tbhZqCkpB

What do the commercial determinants of health look like for goods and services that are human rights? https://t.co/GQLWqLtvZL

“S&P said its downgrade also reflects RP’s corporate decision-making, which “prioritizes the interests of the controlling owners, in line with our view of the majority of rated entities owned by private-equity sponsors.” https://t.co/pcj554f43w

when you ask a seed stage SaaS company how they are able to "easily integrate with any EHR"

Cute discovery of the day while processing some health-related data - found a postcode called 'NORTH POLE' with the number 9999 close to inner-city Melbourne. What is it? @auspost's 'Santa Mail' address. Probably won't be finding any GP clinics there!

When your boss testifies before congress on drug prices & innovation 🔥🔥 @akesselheim: Aducanumab "could've led the government to pay more for one drug than the entire budget of NASA" 🚀 @PORTAL_Research @bnrome @wbfeldman @AmeetSarpatwari @DavalJoseph @AdamR_PhD @DrHussainL

I'm passionate about health affordability & access, but this is more personal - @garmstrongscott and I write in @NZStuff about how NZ's fertility system discriminates against same-sex couples, requiring $$$ to have a child. Policies should change.

Some comments from me on the proposal by @stephenjduckett to change the basis of Medicare access by doctors from a right to a privilege:

Fascinating study. But the real question is whether interns can get AI-guided cardiac echo done on the weekend or a holiday??!?

Well this isn't typical @Health_Affairs commentary. The stakes couldn't be higher for Medicare and those who depend on it. Sadly, value-based care is losing credibility fast. #PrimaryCare https://t.co/wdv2kTnM4T

Many thanks to @Jakob_Emerson @beckersHR for covering our study: https://t.co/TbtamBaH7F. Link to @Health_Affairs Forefront: https://t.co/xuZhfT2BfL @CM_Whaley @RANDCorporation

.@Sen_JoeManchin meanwhile says pharmacy benefit managers are his "number one concern" when it comes to high drug prices.

The Medicare Payment Advisory Commission (MedPAC) finds that Medicare spends 6% more for Medicare Advantage (MA) enrollees than it would spend if they were enrolled in traditional Medicare. That’s $27 billion more spending in 2023. 1/

Pretty telling example of how policy shapes behavior in healthcare. 340B is a huge financial boon for nonprofit hospitals to get favorable drug pricing. But a hospital is only eligible for 340B if it treats over 11.75% of low-income Medicare/Medicaid patients. So - hospitals

Great work by @kennedy_school colleague @sanjayreddy303 and @PORTAL_Research looking at how branded inhaler manufacturers have kept out competition - great read

The plan would give the administration authority to negotiate what price the federal government pays for more drugs than the limited number approved as part of Democrats’ legislative package last year, while also speeding up the process for negotiations.

Thoughtful commentary on how drug manufacturers are likely to "game" the system to avoid full impacts of #IRA price negotiation provisions.